News & Perspective

Feb 19, 2018

Feb 19, 2018
Drawing vaccine from a vial

Senate bill would jump-start universal flu vaccine efforts

The proposed law would direct $200 million a year for 5 years to research.

Sep 28, 2017

Sep 28, 2017
Flu shot

Officials highlight flu vaccination gaps, progress ahead of season

Coverage in adults over 50 increased, but immunization reached only 46.8% of the US population.

Jul 02, 2015

Jul 02, 2015
Vaccine vials

GSK upgrade delays supply of adjuvanted H5N1 vaccine

A recommendation for occupational use was tabled until the vaccine becomes available.

Oct 27, 2014

Oct 27, 2014

CSL-Novartis deal includes US cell-based flu vaccine plant

The $275 million deal will make the company the second leading player in the $4 billion global flu vaccine market.

Jun 16, 2014

Jun 16, 2014
Novartis Holly Springs

FDA OKs Novartis's US cell-based flu vaccine facility

The agency has approved a plant in Holly Springs, N.C.

Oct 02, 2013

Oct 02, 2013
flu vaccine vial

HHS: Fill-and-finish contracts will boost flu vaccine capacity

New federal contracts establish a "fill and finish" network for flu vaccine to boost capacity by 20%.

May 10, 2013

May 10, 2013

Experts offer dim view of potential vaccine response to H7N9

If the H7N9 influenza virus now circulating in China evolves into a pandemic strain, the world is likely to have great difficulty providing adequate supplies of an effective vaccine in time to blunt its impact, according to a viewpoint article by three experts in the Journal of the American Medical Association (JAMA).

Pages

by Topic

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»